155 related articles for article (PubMed ID: 37129468)
1. Projected long-term effects of colorectal cancer screening disruptions following the COVID-19 pandemic.
Nascimento de Lima P; van den Puttelaar R; Hahn AI; Harlass M; Collier N; Ozik J; Zauber AG; Lansdorp-Vogelaar I; Rutter CM
Elife; 2023 May; 12():. PubMed ID: 37129468
[TBL] [Abstract][Full Text] [Related]
2. Unequal Recovery in Colorectal Cancer Screening Following the COVID-19 Pandemic: A Comparative Microsimulation Analysis.
de Lima PN; van den Puttelaar R; Hahn AI; Harlass M; Collier N; Ozik J; Zauber AG; Lansdorp-Vogelaar I; Rutter CM
medRxiv; 2022 Dec; ():. PubMed ID: 36597528
[TBL] [Abstract][Full Text] [Related]
3. Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study.
de Jonge L; Worthington J; van Wifferen F; Iragorri N; Peterse EFP; Lew JB; Greuter MJE; Smith HA; Feletto E; Yong JHE; Canfell K; Coupé VMH; Lansdorp-Vogelaar I;
Lancet Gastroenterol Hepatol; 2021 Apr; 6(4):304-314. PubMed ID: 33548185
[TBL] [Abstract][Full Text] [Related]
4. Prioritisation of colonoscopy services in colorectal cancer screening programmes to minimise impact of COVID-19 pandemic on predicted cancer burden: A comparative modelling study.
van Wifferen F; de Jonge L; Worthington J; Greuter MJE; Lew JB; Nadeau C; van den Puttelaar R; Feletto E; Yong JHE; Lansdorp-Vogelaar I; Canfell K; Coupé VMH;
J Med Screen; 2022 Jun; 29(2):72-83. PubMed ID: 35100894
[TBL] [Abstract][Full Text] [Related]
5. Management of colorectal cancer screening backlog due to the COVID-19 pandemic: A retrospective analysis of the use of a colorectal cancer screening clinical-decision support tool in Argentina.
Pereyra L; Steinberg L; Lasa J; Marconi A; Calderwood AH; Pellisé M
Gastroenterol Hepatol; 2024 Feb; 47(2):140-148. PubMed ID: 36934841
[TBL] [Abstract][Full Text] [Related]
6. When History and Heterogeneity Matter: A Tutorial on the Impact of Markov Model Specifications in the Context of Colorectal Cancer Screening.
Townsley RM; Koutouan PR; Mayorga ME; Mills SD; Davis MM; Hasmiller Lich K
Med Decis Making; 2022 Oct; 42(7):845-860. PubMed ID: 35543440
[TBL] [Abstract][Full Text] [Related]
7. Canadian Landscape Assessment of Colorectal Cancer Screening during the COVID-19 Pandemic.
El Bizri M; Hamidi MW; Mksyartinian P; Stein BD
Curr Oncol; 2023 Oct; 30(10):8973-8991. PubMed ID: 37887548
[TBL] [Abstract][Full Text] [Related]
8. The impact of COVID-19 on national program of colorectal cancer screening in Tehran, Iran: a multicenter study.
Sadeghi A; Asadzadeh Aghdaei H; Khalafi MA; Nazemalhosseini-Mojarad E; Ketabi Moghadam P; Sohrabi MR
BMC Cancer; 2023 Jul; 23(1):627. PubMed ID: 37407931
[TBL] [Abstract][Full Text] [Related]
9. Impact and Recovery from COVID-19-Related Disruptions in Colorectal Cancer Screening and Care in the US: A Scenario Analysis.
van den Puttelaar R; Lansdorp-Vogelaar I; Hahn AI; Rutter CM; Levin TR; Zauber AG; Meester RGS
Cancer Epidemiol Biomarkers Prev; 2023 Jan; 32(1):22-29. PubMed ID: 36215205
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 and inequities in colorectal and cervical cancer screening and diagnosis in Washington State.
Amram O; Amiri S; Robison J; Pflugeisen CM; Monsivais P
Cancer Med; 2022 Aug; 11(15):2990-2998. PubMed ID: 35304835
[TBL] [Abstract][Full Text] [Related]
11. Potential global loss of life expected due to COVID-19 disruptions to organised colorectal cancer screening.
Worthington J; van Wifferen F; Sun Z; de Jonge L; Lew JB; Greuter MJE; van den Puttelaar R; Feletto E; Lansdorp-Vogelaar I; Coupé VMH; Ein Yong JH; Canfell K;
EClinicalMedicine; 2023 Aug; 62():102081. PubMed ID: 37538541
[TBL] [Abstract][Full Text] [Related]
12. A delay in the diagnosis of colorectal cancer screened by fecal immunochemical tests during the COVID-19 pandemic: a longitudinal cohort study.
Ishibashi F; Shida D; Suzuki S; Nagai M; Mochida K; Morishita T
Int J Colorectal Dis; 2022 Dec; 37(12):2543-2546. PubMed ID: 36383225
[TBL] [Abstract][Full Text] [Related]
13. Modelling optimal use of temporarily restricted colonoscopy capacity in a FIT-based CRC screening program: Application during the COVID-19 pandemic.
de Jonge L; van de Schootbrugge-Vandermeer HJ; Breekveldt ECH; Spaander MCW; van Vuuren HJ; van Kemenade FJ; Dekker E; Nagtegaal ID; van Leerdam ME; Lansdorp-Vogelaar I
PLoS One; 2022; 17(6):e0270223. PubMed ID: 35749423
[TBL] [Abstract][Full Text] [Related]
14. Epidemiologic disparities in colon cancer screening and adherence during the COVID-19 pandemic: a retrospective cohort analysis.
Nwankwo EC; Hendrix C; Pollard K; Kallal C; Cruschiel T; Buckhold F; Hachem C
Int J Colorectal Dis; 2022 Apr; 37(4):849-854. PubMed ID: 35275279
[TBL] [Abstract][Full Text] [Related]
15. Impact of the COVID-19 Pandemic on Colorectal Cancer Screening: a Systematic Review.
Mazidimoradi A; Tiznobaik A; Salehiniya H
J Gastrointest Cancer; 2022 Sep; 53(3):730-744. PubMed ID: 34406626
[TBL] [Abstract][Full Text] [Related]
16. [Évaluation de la gravité du cancer colorectal dépisté dans le contexte de la crise sanitaire liée au COVID19 en région Ile-de-France].
Koïvogui A; Abihsera G; Le Trong T; Ait-Hadad H; Bernoux A; Delattre H; Vincelet C; Caroll R; Nicolet J
Rev Epidemiol Sante Publique; 2023 Oct; 71(5):102124. PubMed ID: 37451076
[TBL] [Abstract][Full Text] [Related]
17. Impact of the COVID-19 pandemic in colorectal cancer diagnosis and presentation.
Hijos-Mallada G; Alfaro E; Navarro M; Cañamares P; Ariño I; Charro M; Bruno C; Solano M; Pardillos A; Jimeno C; Carrera-Lasfuentes P; Lanas A; Domper-Arnal MJ
Gastroenterol Hepatol; 2023 Nov; 46(9):702-709. PubMed ID: 36716926
[TBL] [Abstract][Full Text] [Related]
18. Modelling the impacts of COVID-19 pandemic on the quality of population-based colorectal cancer screening.
Jen GH; Yen AM; Hsu CY; Chiu HM; Chen SL; Chen TH
Prev Med; 2021 Oct; 151():106597. PubMed ID: 34217416
[TBL] [Abstract][Full Text] [Related]
19. Impact of social determinants of health on colorectal cancer screening and surveillance in the COVID reopening phase.
Choy AM; Lebwohl B; Krigel A
Eur J Gastroenterol Hepatol; 2022 Jul; 34(7):739-743. PubMed ID: 35102113
[TBL] [Abstract][Full Text] [Related]
20. Inequalities in colorectal cancer screening uptake in Wales: an examination of the impact of the temporary suspension of the screening programme during the COVID-19 pandemic.
Bright D; Hillier S; Song J; Huws DW; Greene G; Hodgson K; Akbari A; Griffiths R; Davies AR; Gjini A
BMC Public Health; 2023 Mar; 23(1):546. PubMed ID: 36949447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
